Founded in 1972 and located in proximity of the National Institutes of Health (NIH) and of the Food and Drug Administration (FDA), the Biostatistics Center is celebrating 50 years of groundbreaking research that has improved the health outcomes and quality of life for millions of people worldwide. The Center has a 50-year history of leadership in practice-changing clinical trials and biostatistical methodology research. Research studies conducted by the Center have been: recognized in reports to the United States President and Congress, cited in reports from the United States White House, recognized in Time Magazine’s The Year in Medicine, named the #1 advance in medicine by the Harvard Health Letter, received the Society for Clinical Trials (SCT) “Trial of the Year” Award, received the Norman F. Gant Award for best research in maternal medicine, recognized in Clinical Research Forum’s Top Ten Awards, featured in People magazine, recognized in “Drazen’s Dozen”. The Center has published over 60 publications in the New England Journal of Medicine, and hundreds in other medical journals, and over 250 methodological publications.
The Center’s mission is to: provide leadership and expertise in the execution of all types of studies including clinical trials, observational studies, genetics and diagnostic studies; to foster biostatistical science by developing and implementing innovative approaches for the design, monitoring, analysis, and reporting of clinical research studies; and to provide training and education relevant to clinical trials and other clinical research.
The Center has a staff of over 110 with more than 40 biostatisticians/epidemiologists that includes more Fellows of the Society for Clinical Trials (SCT) than any other institution. Twenty faculty members at the Center provide biostatistical leadership and manage $60-65 million annually for projects in medical areas such as diabetes, maternal fetal medicine, infectious disease, and cardiovascular disease.
For further information about the Center, please see:https://biostatcenter.gwu.edu/ .
Launched in summer of 2019, the Department of Biostatistics and Bioinformatics elevates Milken Institute School of Public Health’s commitment to the quantitative sciences and supports the university-wide focus on science, technology, engineering and math (STEM). The vision of the Department is to improve public health through excellence in education and teaching in biostatistics and bioinformatics, transformative scientific research, and dedicated service to the university, profession and community.
For further information about DBB, please see: https://publichealth.gwu.edu/departments/biostatistics-and-bioinformatics .
The Department of Epidemiology has 23 full-time faculty and 24 part-time faculty, with a majority funded by NIH and/or CDC. Key areas of funded research in the Department currently include HIV and other infectious diseases, public health laboratory research in HIV and other infectious diseases, cancer, diabetes, maternal/fetal health, substance and tobacco use, and Alzheimer’s Disease and related dementias.
For further information about DEPI, please see: https://publichealth.gwu.edu/departments/epidemiology .
Additional information about the Milken Institute SPH can be found at: http://publichealth.gwu.edu/.